These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23333413)

  • 1. Cellular immunogenicity of a multi-epitope peptide vaccine candidate based on hepatitis C virus NS5A, NS4B and core proteins in HHD-2 mice.
    Huang XJ; Lü X; Lei YF; Yang J; Yao M; Lan HY; Zhang JM; Jia ZS; Yin W; Xu ZK
    J Virol Methods; 2013 Apr; 189(1):47-52. PubMed ID: 23333413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice.
    Holmström F; Pasetto A; Nähr V; Brass A; Kriegs M; Hildt E; Broderick KE; Chen M; Ahlén G; Frelin L
    J Immunol; 2013 Feb; 190(3):1113-24. PubMed ID: 23284053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
    J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected].
    Lang Kuhs KA; Ginsberg AA; Yan J; Wiseman RW; Khan AS; Sardesai NY; O'Connor DH; Weiner DB
    Mol Ther; 2012 Mar; 20(3):669-78. PubMed ID: 21952169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and memory T cell responses induced by hepatitis C virus multiepitope long peptides.
    Fournillier A; Dupeyrot P; Martin P; Parroche P; Pajot A; Chatel L; Fatmi A; Gerossier E; Bain C; Lone YC; Trépo C; Inchauspé G
    Vaccine; 2006 Apr; 24(16):3153-64. PubMed ID: 16481078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus.
    Hiranuma K; Tamaki S; Nishimura Y; Kusuki S; Isogawa M; Kim G; Kaito M; Kuribayashi K; Adachi Y; Yasutomi Y
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():187-193. PubMed ID: 9934701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells.
    Mishra S; Losikoff PT; Self AA; Terry F; Ardito MT; Tassone R; Martin WD; De Groot AS; Gregory SH
    Vaccine; 2014 May; 32(26):3285-92. PubMed ID: 24721533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of three adjuvants enhances the immunogenicity of a recombinant protein containing the CTL epitopes of non-structural proteins of hepatitis C virus.
    Kuprianov VV; Nikolaeva LI; Zykova AA; Dedova AV; Grishechkin AE; Kapustin IV; Kotlyarov RY; Ravin NV
    Virus Res; 2020 Jul; 284():197984. PubMed ID: 32325116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized vaccination regimen linked to exhaustive screening approaches identifies 2 novel HLA-B7 restricted epitopes within hepatitis C virus NS3 protein.
    Martin P; Parroche P; Pajot A; Chatel L; Barreto C; Touat L; Dubois V; Rohrlich PS; Bain C; Trépo C; Negro F; Inchauspé G; Fournillier A
    Microbes Infect; 2006 Aug; 8(9-10):2432-41. PubMed ID: 16859951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro CD8 T-cell priming assay enables epitope selection for hepatitis C virus vaccines.
    Koutsoumpli G; Stasiukonyte N; Hoogeboom BN; Daemen T
    Vaccine; 2024 Sep; 42(22):126032. PubMed ID: 38964950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses.
    Vajdy M; Selby M; Medina-Selby A; Coit D; Hall J; Tandeske L; Chien D; Hu C; Rosa D; Singh M; Kazzaz J; Nguyen S; Coates S; Ng P; Abrignani S; Lin YL; Houghton M; O'Hagan DT
    J Gen Virol; 2006 Aug; 87(Pt 8):2253-2262. PubMed ID: 16847121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA immunization with a plasmid containing gene of hepatitis C virus protein 5A (NS5A) induces the effective cellular immune response].
    Masalova OV; Lesnova EI; Grabovetskiĭ VV; Smirnova OA; Ulanova TI; Burkov AN; Ivanov AV; Zaberezhnyĭ AD; Ataullakhanov RI; Kushch AA
    Mol Biol (Mosk); 2010; 44(2):275-83. PubMed ID: 20586188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
    Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
    J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.
    Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Márquez-Galán JL; Núñez-Roldán A; Aguilar-Reina J
    Liver Int; 2014 Jul; 34(6):e80-8. PubMed ID: 24127783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
    Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
    Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.